Fenebrutinib
Drug timelines are a Plus or Pro feature.
6 regulatory and trial events tracked for Fenebrutinib, covering 2020-09-25 to 2026-04-13. Get the full timeline:
Most recent: Clinical Trial Update: A Pharmacokinetics (PK), Pharmacodynamics (PD), Safety and Tolerability Study of Fenebrutinib in Children and Adolescents With Relapsing Multiple Sclerosis (RMS) [Phase 2]